Xalatan
Xalatan
- In our pharmacy, you can buy xalatan without a prescription, with delivery in 5–14 days throughout the United Kingdom; discreet and anonymous packaging. Note: xalatan is prescription‑only in most countries, and legal availability without a prescription may vary by supplier and jurisdiction.
- Xalatan (latanoprost) is used to lower elevated intraocular pressure in open‑angle glaucoma and ocular hypertension; it is a prostaglandin analogue that increases uveoscleral outflow of aqueous humour to reduce IOP.
- The usual dose is one drop of 0.005% (0.05 mg/mL) in the affected eye once daily, preferably in the evening; dosing more frequently does not increase efficacy.
- Administration is topical as an ophthalmic solution, available as multidose dropper vials (typically 2.5 mL or 5 mL) and preservative‑free single‑dose containers.
- Onset of action is within about 3–4 hours, with measurable IOP reduction on the first day and increasing effect over days to weeks (maximum effect often by about 4 weeks).
- Duration of action is approximately 24 hours, allowing once‑daily dosing.
- There is no known significant interaction with alcohol, but avoid excessive alcohol as it can worsen ocular dryness or irritation; consult a clinician if you have respiratory disease or other health concerns.
- The most common side effect is increased iris pigmentation (darkening of the coloured part of the eye); other common effects include eyelash growth, periocular skin darkening and mild conjunctival hyperaemia.
- Would you like to try xalatan without a prescription?
Basic Xalatan Information
- INN (International Nonproprietary Name): Latanoprost
- Brand Names Available In United Kingdom: not specified
- ATC Code: S01EE01 — S01 (Ophthalmologicals); EE (Prostaglandin Analogues); 01 (Latanoprost)
- Forms & Dosages: Ophthalmic solution 0.005% (0.05 mg/mL) in multidose dropper vials (2.5 mL, 5 mL) and preservative‑free single‑dose containers of 0.005%.
- Manufacturers In United Kingdom: not specified
- Registration Status In United Kingdom: not specified
- OTC / Rx Classification: Prescription only medicine (Rx) in most countries, including EU/UK
Latest Research Highlights (UK & EU, 2022–2025)
Worried whether Xalatan and other latanoprost products still work as well as before?
Recent UK and European evidence from 2022–2025 confirms that latanoprost 0.005% formulations remain effective at lowering intraocular pressure (IOP) in open‑angle glaucoma and ocular hypertension.
NHS audits and real‑world registry analyses report average IOP reductions of about 25–30% from baseline with once‑daily evening dosing.
Comparative trials and audits show preservative‑free versions such as Monoprost and Iyuzeh associate with fewer ocular surface symptoms in real‑world registries.
European pharmacovigilance submissions to EMA and MHRA reiterate common local effects — iris pigmentation change, eyelash alterations and conjunctival hyperaemia — with rare post‑marketing reports of macular oedema and uveitis.
| Study / Audit | Population | Mean IOP Change | Adverse Events |
|---|---|---|---|
| UK NHS Real‑World Audit (2022–2024) | Mixed open‑angle glaucoma patients | ≈25–30% reduction | Iris pigmentation, eyelash changes, conjunctival hyperaemia |
| European Registry Analysis (2023) | Patients switching to preservative‑free | Sustained IOP control | Reduced ocular surface symptoms vs preserved formulations |
Clinical Effectiveness In The UK (NHS Outcomes & Patient Reports)
Do patients on Xalatan keep their pressure controlled in everyday NHS care?
NHS primary and secondary care audits show latanoprost (S01EE01) is a common first‑line prostaglandin analogue for IOP lowering in open‑angle glaucoma and ocular hypertension.
Real‑world NHS data indicate most patients maintain sustained IOP control when they adhere to once‑daily evening dosing of one drop of 0.005% in the affected eye.
Fewer patients require escalation to additional agents compared with some alternatives in local audits.
- IOP Change: mean 25–30% reduction from baseline in audits.
- Escalation Rate: lower than some comparator agents in practice audits.
- Adherence Rates: improved when dosing is simplified to once daily in the evening.
| Patient‑Reported Theme | Typical Feedback |
|---|---|
| Effectiveness | Improved visual field stability reported in many clinics |
| Comfort | Minor ocular surface discomfort in a minority; preservative‑free often preferred |
Prescription only status means ophthalmic monitoring via NHS outpatient clinics is recommended.
Indications And Expanded Uses (MHRA‑Approved And Off‑Label)
What is Xalatan officially licensed to treat, and when do specialists use it differently?
MHRA/EMA‑aligned indications for latanoprost 0.005% are the reduction of elevated IOP in open‑angle glaucoma and ocular hypertension.
Off‑label uses within UK ophthalmology include adjunctive therapy in complex glaucoma subtypes and select paediatric cases under specialist care, where consultant approval and careful monitoring are required.
- MHRA‑Approved: Open‑angle glaucoma; ocular hypertension — 1 drop 0.005% once daily (evening preferred).
- Off‑Label: Specialist use in paediatric glaucoma and complex secondary glaucomas when clinically justified.
| Indication | Evidence Level |
|---|---|
| Open‑Angle Glaucoma | High — licensed indication |
| Ocular Hypertension | High — licensed indication |
| Paediatric/Complex Glaucoma | Limited — off‑label specialist use |
Do not increase dosing frequency — more frequent administration may reduce efficacy.
Composition And Brand Landscape (Active Ingredients, UK Brands, Generics)
Which products are identical to Xalatan, and what choices do patients have?
The active ingredient across all these products is latanoprost (INN), typically formulated at 0.005% (0.05 mg/mL).
Market products include the innovator Xalatan (Viatris/Pfizer) and multiple generics marketed globally by manufacturers such as Sun Pharma and Glenmark.
Preservative‑free single‑dose brands increasingly available in Europe include Monoprost and Iyuzeh from Théa.
| Brand | Manufacturer / Distributor | Packaging | Preservative Status |
|---|---|---|---|
| Xalatan | Viatris (Pfizer) | 2.5 mL, 5 mL dropper vials | Preserved (standard) |
| Monoprost | Théa | Single‑dose containers | Preservative‑free |
| Iyuzeh | Thea Pharma | Single‑dose vials | Preservative‑free |
| Generic Latanoprost | Sun Pharma, Glenmark, others | 2.5 mL, 5 mL dropper vials | Varies |
ATC classification is S01EE01 and products are available through community pharmacies (Boots, LloydsPharmacy, Superdrug) and NHS prescribing, although specific brand supply may be hospital‑driven in tertiary clinics.
Contraindications And Special Precautions (High‑Risk Groups)
Who should not use latanoprost without specialist review?
Absolute contraindications include known hypersensitivity to latanoprost or any component of the formulation, and a history of herpetic keratitis.
Relative precautions include active intraocular inflammation (uveitis), aphakia or pseudophakia with a torn posterior capsule due to the risk of macular oedema, and severe asthma where monitoring for respiratory symptoms is advised.
Pregnancy and breastfeeding have limited human data; specialist advice is recommended before initiating treatment.
- Driving/Work: Transient blurred vision may occur after instillation — advise patients not to drive until vision clears.
- Reporting: Suspected severe reactions should be reported via the MHRA Yellow Card scheme.
Use clinical judgement and ophthalmology follow‑up when managing high‑risk patients.
Dosage Guidelines (NHS‑Recommended Regimens & Adjustments)
How should Xalatan be used for best effect?
The standard NHS regimen is one drop of latanoprost 0.005% into the affected eye(s) once daily in the evening.
Emphasise to patients that dosing more frequently does not increase effect and may reduce the IOP‑lowering benefit.
| Group | Recommendation |
|---|---|
| Adults | 1 drop 0.005% once daily (evening) |
| Children | Limited data — consult specialist |
| Elderly | No routine adjustment required |
Storage checklist: refrigerate at 2–8°C before opening; after opening store below 25°C, protect from light and discard after 4–6 weeks per local labelling.
Missed dose guidance: give the same day if remembered; do not double up the next dose.
Interactions Overview (Drugs, Food, MHRA Reports)
Will latanoprost interact with other medicines or foods?
Systemic interactions are uncommon because systemic absorption is minimal with topical ocular application.
Concurrent topical ocular medications should be managed to avoid overlapping prostaglandin therapy or incompatibilities; separate instillations by a few minutes when multiple drops are required.
No significant interactions with food or drink are documented, but caution is advised in severe asthma patients and those on respiratory medicines because rare bronchospasm has been reported.
| Interaction Type | Notes |
|---|---|
| Topical Ocular Agents | Avoid duplicating prostaglandin analogues; space drops if needed |
| Systemic Respiratory Meds | Monitor in severe asthma for rare bronchospasm |
| MHRA Yellow Card Signals | Rare reports of macular oedema and uveitis linked to intraocular inflammation |
Prescribers should monitor and report suspected severe adverse events through MHRA pharmacovigilance.
Cultural Perceptions And Patient Habits (UK Patient Forums & Trust Patterns)
What do UK patients say about Xalatan on forums and in clinic feedback?
UK patient forums and NHS patient feedback commonly show trust in pharmacist counselling and NHS ophthalmology follow‑up when starting latanoprost.
Frequent themes include anxiety about lifelong therapy, cosmetic worries about iris darkening and eyelash growth, and a preference for preservative‑free options if the ocular surface becomes uncomfortable.
Community pharmacists at Boots and LloydsPharmacy are regularly consulted for administration tips, and patients use NHS 111 or local GPs for urgent concerns.
| Sentiment | Typical Comments |
|---|---|
| Positive | Good pressure control; once‑daily dosing convenient |
| Negative | Worry about cosmetic change; some ocular irritation with preserved drops |
Electronic prescribing and NHS patient portals often make repeat supply and clinic communication easier for patients on long‑term drops.
Availability And Pricing Patterns (UK Pharmacies, NHS Vs Private Costs)
How do patients in the UK get Xalatan and what does it cost?
Latanoprost is prescription‑only in the UK and is supplied via NHS prescription or private prescription to chains such as Boots, LloydsPharmacy and Superdrug and to online pharmacies.
Regional differences in cost arise because prescription charges apply in England but prescriptions are free in Scotland, Wales and Northern Ireland.
Private prices vary by brand and preservative status: generics are typically less expensive while preservative‑free brands such as Monoprost are often costlier.
| Route | Typical Cost Example |
|---|---|
| NHS Prescription (England) | Standard prescription charge applies |
| NHS Prescription (Scotland/Wales/NI) | Prescriptions usually free |
| Private Purchase | Cost depends on brand; generics cheaper, preservative‑free higher |
Where to obtain a prescription: GP following optometrist referral, optometrist with prescribing rights, hospital eye service or electronic prescription for community pharmacy supply.
In our online pharmacy, xalatan is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.
Comparable Medicines And Preferences (NHS Alternatives & Checklist)
Which alternatives does the NHS consider when latanoprost is unsuitable?
Key alternative prostaglandin analogues used within NHS care include bimatoprost (for example Lumigan), travoprost (Travatan Z) and tafluprost (preservative‑free Saflutan).
Choice depends on IOP response, tolerability, preservative sensitivity and local formulary cost decisions.
| Active | Preservative Status | Typical Side Effects | Relative Cost |
|---|---|---|---|
| Latanoprost | Preserved and preservative‑free options | Iris darkening, eyelash change | Moderate (generics lower) |
| Bimatoprost | Preserved | More hyperaemia, lash growth | Variable |
| Tafluprost | Preservative‑free options | Better tolerated on ocular surface | Often higher |
Prescribers should consult local NHS formulary choices and hospital glaucoma clinic guidance when selecting an agent.
FAQ
Will latanoprost change my eye colour?
Possible gradual iris darkening can occur, most commonly in those with mixed or multi‑coloured irides; discuss cosmetic concerns with your clinician before starting therapy.
Can I drive after using drops?
If you experience transient blurred vision after instillation, wait until your vision has cleared before driving or operating machinery.
What if I miss a dose?
If you remember the same day, give the missed dose; if it is near the time for your next dose, skip it — do not double the dose.
Are preservative‑free options available on the NHS?
Sometimes preservative‑free latanoprost is available via hospital clinics or local formularies; ask your specialist or community pharmacist for advice.
For suspected adverse reactions you can report via the MHRA Yellow Card scheme and discuss concerns with your ophthalmology team.
Guidelines For Proper Use (Pharmacist Counselling & NHS Support)
How should a pharmacist explain Xalatan use to a patient starting therapy?
Demonstrate correct instillation technique and provide a stepwise checklist: wash hands, tilt head back, instil one drop into the conjunctival sac, close eye for a minute and blot excess without rubbing.
Advise evening dosing, warn about transient vision blur after instillation and counsel on cosmetic side effects such as iris darkening and eyelash changes.
Storage instructions: refrigerate 2–8°C before opening; after opening store below 25°C, protect from light and discard after 4–6 weeks per labelling.
Provide written NHS leaflets, signpost to local glaucoma clinic contacts and explain how to report adverse events via MHRA Yellow Card.
If the prescribed brand cannot be supplied from community stock, help arrange hospital supply or an alternative as per electronic prescription arrangements.
Delivery Across United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | England | 5-7 days |
| Birmingham | England | 5-7 days |
| Manchester | England | 5-7 days |
| Glasgow | Scotland | 5-7 days |
| Edinburgh | Scotland | 5-7 days |
| Leeds | England | 5-7 days |
| Bristol | England | 5-7 days |
| Cardiff | Wales | 5-7 days |
| Belfast | Northern Ireland | 5-9 days |
| Newcastle | England | 5-9 days |
| Southampton | England | 5-9 days |
| Nottingham | England | 5-9 days |
| Hull | England | 5-9 days |
| Aberdeen | Scotland | 5-9 days |